Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

Abstract Background Rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) are autoimmune disorders associated with an increased risk for depression, anxiety and sleeping problems. The objective of this study was to analyze use of antidepressants and benzodiazepine-rela...

Full description

Bibliographic Details
Main Authors: Philip Brenner, Anna Citarella, Louise Wingård, Anders Sundström
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Rheumatology
Subjects:
Epidemiology
Antidepressants
Sleeping agents
Rheumatoid arthritis
Psoriatic arthritis
Ankylosing spondylitis
Online Access:https://doi.org/10.1186/s41927-019-0106-3

Similar Items

Similar Items